It has been shown in another study that increased FYN expression may contribute to hepatocellular carcinoma metastasis [133].The Wnt5-Fzd2-FYN-Stat3 axis contributes to the EMT program, cell migration, and multiple tumor metastases, and the FYN inhibitor Dasatinib inhibits this process [122]. Here, FYN is linked to hepatocellular carcinoma.